Navamedic ASA announces it has renewed its contract with Vitaflo International Limited (Vitaflo International), granting Navamedic the exclusive rights to market and distribute Vitaflo International's medical nutrition products across the Nordic region for an additional five years. This agreement follows a longstanding partnership between Navamedic and Vitaflo International, dating back to 2005. Vitaflo International's medical nutrition products make up Navamedic's IEM (inborn error of metabolism) products and are part of the Hospital segment.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.1 NOK | -0.90% | +1.53% | -9.81% |
May. 06 | Navamedic Rolls Out Erectile Dysfunction Drug in Sweden | MT |
Apr. 30 | Navamedic ASA Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.81% | 53.2M | |
+30.38% | 684B | |
+26.51% | 568B | |
-4.36% | 361B | |
+19.30% | 329B | |
+3.73% | 284B | |
+16.70% | 240B | |
+8.78% | 208B | |
-7.93% | 200B | |
+7.68% | 166B |
- Stock Market
- Equities
- NAVA Stock
- News Navamedic ASA
- Navamedic ASA Renews Contract Signed with Vitaflo International Limited